Trigg Minerals Limited (ASX:TMG) Announces Antimony Exemption from US Tariffs
Trigg Minerals (ASX:TMG) secures antimony exemption from US tariffs, propelling the development of its Wild Cattle Creek project.
Tag: Regulatory News & Compliance
Abacus Group (ASX:ABG) Receives Acquisition Proposal for ASK
Abacus Group (ASX:ABG) receives unsolicited proposal from Ki Corporation and Public Storage to acquire additional ASK securities.
Dropsuite Limited (ASX:DSE) Declared Unacceptable Circumstances
Dropsuite Limited (ASX:DSE) has been declared to have unacceptable circumstances by the Takeovers Panel due to major shareholder Topline’s non-compliance.
Structural Monitoring Systems PLC (ASX:SMN) Updates on US Tariffs Impact
Structural Monitoring Systems PLC (ASX:SMN) announces an update on US reciprocal tariffs, confirming tariff-free status for its compliant avionics products and ongoing monitoring of trade impacts.
Mesoblast (ASX:MSB) Announces U.S. Tariff Exemption for Allogeneic Cell Therapies
Mesoblast (ASX:MSB) announces its allogeneic cell therapies are exempt from U.S. tariffs as ‘U.S. Country of Origin’ products.
Orthocell Limited (ASX:OCC) Receives FDA Clearance for Remplir™
Orthocell (ASX:OCC) secures FDA clearance for Remplir™, enabling entry into the US $1.6 billion nerve repair market.
Echo IQ (ASX:EIQ) Partners with Mayo Clinic Platform, Advances EchoSolv HF towards FDA Clearance
Echo IQ (ASX:EIQ) partners with Mayo Clinic Platform to advance EchoSolv HF and progress towards FDA clearance for its heart failure solution.
Gold Mountain Limited (ASX:GMN) Announces Entitlement Offer and Director Appointment
Gold Mountain Limited (ASX:GMN) announces a $3.05m entitlement offer and appoints a new director to support its exploration initiatives.
Epsilon Healthcare Limited (ASX:EPN) Enters Voluntary Administration
Epsilon Healthcare Limited (ASX:EPN) enters voluntary administration, resulting in leadership changes and subdued operations.
Cettire Limited (ASX:CTT) Assesses Impact of US Tariff Changes
Cettire Limited (ASX:CTT) assesses the impact of new US tariffs on EU goods, affecting 41% of H1-FY25 sales.